Two Sigma Advisers
AVXL icon

Two Sigma Advisers’s Anavex Life Sciences AVXL Stock Holding History

Two Sigma Advisers’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,209,570
Closed -$4.31M – 217
2025
Q4 		$4.31M Buy
1,209,570
+451,070
+59% +$2.76M 0.01% 879
2025
Q3 		$6.75M Sell
758,500
-64,900
-8% -$658K 0.01% 635
2025
Q2 		$7.59M Buy
823,400
+315,200
+62% +$2.69M 0.02% 602
2025
Q1 		$4.36M Buy
508,200
+17,600
+4% +$166K 0.01% 840
2024
Q4 		$5.27M Sell
490,600
-2,900
-0.6% -$22.3K 0.01% 707
2024
Q3 		$2.8M Sell
493,500
-139,500
-22% -$805K 0.01% 922
2024
Q2 		$2.67M Buy
633,000
+584,500
+1,205% +$2.36M 0.01% 1034
2024
Q1 		$247K Buy
+48,500
New +$273K ﹤0.01% 2139
2023
Q4 		– Sell
-14,200
Closed -$93K – 2496
2023
Q3 		$93K Sell
14,200
-12,700
-47% -$101K ﹤0.01% 2220
2023
Q2 		$219K Sell
26,900
-153,700
-85% -$1.32M ﹤0.01% 2072
2023
Q1 		$1.55M Buy
180,600
+71,500
+66% +$714K ﹤0.01% 1408
2022
Q4 		$1.01M Buy
109,100
+67,500
+162% +$721K ﹤0.01% 1559
2022
Q3 		$429K Buy
41,600
+27,700
+199% +$292K ﹤0.01% 1907
2022
Q2 		$139K Sell
13,900
-17,100
-55% -$162K ﹤0.01% 2347
2022
Q1 		$382K Buy
+31,000
New +$381K ﹤0.01% 2112

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Advisers's AVXL Position: Q1 2026 in Review

Two Sigma Advisers sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 1,209,570 shares — an estimated $4.31M sold.

Two Sigma Advisers first reported a position in AVXL in Q1 2022 and held it in 15 quarters. The position peaked at $7.59M in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Two Sigma Advisers reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,209,570 Anavex Life Sciences shares in Q1 2026, an estimated $4.31M.
  • Two Sigma Advisers first reported a position in Anavex Life Sciences in Q1 2022 and held it in 15 quarters.
  • Two Sigma Advisers's Anavex Life Sciences position peaked at $7.59M in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.